Stem cell research is at the edge of contemporary medicine, where scientists have shown great hope that it brings the ...

Ocugen says it is on track to reshape the market for gene therapies against eye disorders over the next three years, by ...

In July 2025, Novartis Pharmaceuticals organized a study is to assess the effect of Iptacopan to prevent conversion of early ...

The development of drug delivery platforms that offer sustained release of therapeutic agents in the retina represents a ...

Dr. Magdalena Renne, a leading expert in 3D organoid systems, details how her team has overcome longstanding barriers in ...

Australian researchers highlighted the overlooked ocular risks surfers and divers face from UV and blue light exposure.

Malvern, Pennsylvania Tuesday, July 22, 2025, 17:00 Hrs [IST] ...

The retinal pigment epithelium (RPE), a layer of cells supporting photoreceptors, is also affected in people with Stargardt disease. About Ocugen, Inc. Ocugen, Inc. is a biotechnology company focused ...